Phase I trial of the addition of oral topotecan to standard 5-day temozolomide for malignant gliomas.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Kirkpatrick, J; Vredenburgh, JJ; Reardon, DA; Desjardins, A; Peters, K; Gururangan, S; Herndon, JE; Marcello, J; Woodring, S; Friedman, HS

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 2073 - 2073

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.2073


  • en